To access the full text documents, please follow this link: http://hdl.handle.net/10609/85445
dc.contributor | Universitat Oberta de Catalunya. Estudis de Psicologia i Ciències de l'Educació |
---|---|
dc.contributor.author | Muñoz Moreno, Jose Antonio |
dc.contributor.author | Prats, Anna |
dc.contributor.author | Moltó, José |
dc.contributor.author | Garolera Freixa, Maite |
dc.contributor.author | Pérez Álvarez, Núria |
dc.contributor.author | Díez Quevedo, Crisanto |
dc.contributor.author | Miranda, Cristina |
dc.contributor.author | Rodríguez Fumaz, Carmina |
dc.contributor.author | Ferrer, María José |
dc.contributor.author | Clotet, Bonaventura |
dc.date | 2018-10-26T12:04:32Z |
dc.date | 2018-10-26T12:04:32Z |
dc.date | 2017-08-30 |
dc.identifier.citation | Muñoz-Moreno,J., Prats, A., Moltó, J., Garolera, M., Pérez-Álvarez N, Díez-Quevedo C, et al. (2017). Transdermal rivastigmine for HIVassociated cognitive impairment: A randomized pilot study. PLoS ONE 12(8), e0182547. doi: 10.1371/journal.pone.0182547 |
dc.identifier.citation | 10.1371/journal.pone.0182547 |
dc.identifier.citation | http://www.doi.org/10.1371/journal.pone.0182547 |
dc.identifier.citation | PMC5576750 (PMC) |
dc.identifier.uri | http://hdl.handle.net/10609/85445 |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Plos One |
dc.relation | PLoS ONE, 2017, 12(8) |
dc.relation | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0182547 |
dc.relation | info:eu-repo/grantAgreement/EC10-320 |
dc.relation | info:eu-repo/grantAgreement/B-904 |
dc.rights | CC BY |
dc.rights | https://creativecommons.org/licenses/by/4.0/ |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | cognitive impairment |
dc.subject | combination antiretroviral therapy |
dc.subject | deterioro cognitivo |
dc.subject | tratamiento antirretroviral combinado |
dc.subject | deterioració cognitiva |
dc.subject | tractament antiretroviral combinat |
dc.subject | AIDS (Disease) |
dc.subject | Sida |
dc.subject | Sida |
dc.title | Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |